Level C· Early human research exploring benefitsRetrospective StudyEurope PMCOpen access

The Role of Urinary Bladder Matrix in Preserving Length and Function After Fingertip Injury

McCullough MC., Ebner PJ., Brown T., Williams E., Tanabe K., Berihun H.

Retrospective Study with a reported sample of 10 on Chronic Wound, published in Plast Reconstr Surg Glob Open (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Plast Reconstr Surg Glob Open (2025)
Reported sample size
10
Source database
Europe PMC
PMID
40989944
PMCID
PMC12453368
DOI
10.1097/gox.0000000000007011

Abstract (original English)

Background Fingertip injuries are an overwhelmingly common but potentially debilitating injury. Preservation of functional length with restoration of sensate, supple tissue is the primary goal of reconstruction. Urinary bladder matrix (UBM) can serve as a tissue regenerator and replacement that can be kept moist with a dual-layer dressing, reducing painful dressing changes to every 10 days. Methods A retrospective review was performed analyzing all patients treated with UBM for hand and finger injuries at a single institution between 2020 and early 2024. Patient demographics were recorded, including age, sex, level of injury, mechanism of injury, and prior treatments. Surgical outcomes, including time to wound healing, necessity of skin grafting, and postoperative complications, were collected. Results A total of 23 cases were identified. Mechanisms of injury included traumatic amputation/crush (n = 10), burn injury (n = 1), dog bite (n = 1), ballistic trauma (n = 1), cancer excision (n = 1), septic flexor tenosynovitis requiring debridement (n = 1), and ischemic necrosis (n = 8). All patients underwent surgical debridement followed by application of UBM. Six of 23 patients required secondary skin grafting to achieve full healing. The product was successfully used after preexisting infection in 3 cases. The average time to wound healing was 9.8 weeks (SD 3.4 wk). Conclusions Fi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research